#Bioretec #Finland #Tampere #Orthopedic Implants #Sarah van Hellenberg

Bioretec Elevates Sarah van Hellenberg Hubar-Fisher to Chief Executive Officer

TAMPERE, Finland — In a strategic move to enhance its position in the healthcare industry, Bioretec Ltd., a leading innovator in absorbable orthopedic implants, has appointed Sarah van Hellenberg Hubar-Fisher as the new Chief Executive Officer (CEO), effective immediately. This decision follows her successful tenure as the interim CEO since May 2025, during which she significantly contributed to the company's strategic advancements.

Van Hellenberg Hubar-Fisher has been an integral part of Bioretec since 2021, serving on the Board of Directors alongside her responsibilities as the Vice Chairperson. Her extensive background in medical technology positions her as an ideal leader to spearhead Bioretec’s growth trajectory. With an extensive career spanning over two decades in healthcare and public health, she has demonstrated a proven ability to translate innovative technologies into successful real-world applications.

In her new capacity, she aims to drive forward the company’s commercial strategies, particularly in light of recent regulatory approvals that will facilitate Bioretec's expansion into global markets. “Sarah's impactful leadership during her interim role has inspired confidence among our team and stakeholders,” remarked Kustaa Poutiainen, the Chairperson of the Board. “We are excited for her to guide Bioretec as we aim for global leadership in absorbable orthopedic implant solutions.”

Key Focus Areas for Growth
Van Hellenberg Hubar-Fisher has outlined clear goals for the company, primarily focusing on accelerating the global launch of their flagship product, RemeOs™, and building upon the success of their established Activa® product line. With RemeOs recently obtaining CE mark approval and Activa demonstrating sustained market success, Bioretec is poised for significant growth. “I am enthusiastic about leading Bioretec into its next phase, where we prioritize innovative orthopedic technologies that enhance patient outcomes,” she stated.

Experience and Expertise
The newly appointed CEO carries a wealth of experience from various leadership roles, including significant positions at Johnson & Johnson. She has also worked as a Venture Partner at Nina Capital in Spain and Growth Science Ventures in the United States. Van Hellenberg Hubar-Fisher has a strong academic foundation with an MBA in Entrepreneurship from Babson College and a postgraduate degree in Global Business from the University of Oxford. In addition to her CEO role at Bioretec, she contributes to Global Surgical Initiatives, a nonprofit focused on improving surgical care access in underserved areas.

Bioretec’s Vision and Innovations
Bioretec is recognized for its pioneering work in developing biodegradable implants that promote natural bone growth and accelerate healing post-surgery. Each of Bioretec’s offerings—including the fully absorbable Activa® implants—are based on proprietary self-reinforced PLGA polymers designed to degrade over approximately two years, thereby eliminating the need for surgical removal while supporting optimal bone healing. Furthermore, the company's RemeOs™ line, crafted from a high-performance magnesium alloy combined with hybrid composites, represents advanced technology in surgical practices, effectively mimicking natural bone and improving recovery metrics.

A Future Focused on Patient-Centric Solutions
As the company sets its sight on further innovation, Bioretec prepares to lead discussions on best practices and advancements in the orthopedic domain, addressing the necessity for durable yet dissolvable surgical solutions. Van Hellenberg Hubar-Fisher’s leadership promises to play a central role in manifesting Bioretec's long-term vision, prioritizing not just product expansion but also enhancing the overall quality of care for patients worldwide. By driving forward solutions that minimize invasive procedures, Bioretec aims to create long-term value for its stakeholders and make significant strides in the orthopedic field.

To learn more about Bioretec and their revolutionary products, visit Bioretec's official website.